The biopharma industry loses approximately $35 billion annually due to failures in temperature-controlled logistics, according to data from the IQVIA Institute for Human Data Science. These numbers fail to quantify the risks that compromised pharmaceutical products pose for human health. As a result of temperature excursions during transport or storage, pharmaceutical products not only become ineffective, but can also lead to life-threatening consequences for human beings who